相关实验视频

Updated: Jun 10, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

在瘤微环境中针对性调节髓质衍生抑制细胞:对癌症治疗的影响

Yafeng Qi¹, Liying Zhang², Yeyuan Liu¹

¹Clinical School of Traditional Chinese Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730000, China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|October 18, 2024

概括

骨髓系衍生抑制细胞 (MDSCs) 是瘤免疫逃避和进展的关键参与者. 针对MDSCs,可能与传统中医 (TCM) 合作,提供了一种有前途的策略,以增强抗瘤免疫力并改善癌症治疗结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

骨髓衍生抑制细胞 (MDSCs) 是不成熟的骨髓细胞,具有强大的免疫抑制功能.
MDSCs对瘤免疫逃避,进展和对治疗的抵抗有显著的贡献.

研究的目的:

提供MDSC与瘤相互作用及其机制的全面分析.
审查MDSC向治疗的进展,并探索中国传统医学 (TCM) 在调节MDSC方面的潜力.

主要方法:

文献综述和对癌症中MDSCs现有研究的分析.
探索MDSC表型,免疫抑制机制和瘤生物学中的作用.
讨论针对MDSCs的治疗策略和TCM的作用.

主要成果:

在转移前的利基形成,血管新生,血管透性,亡抑制和治疗耐药性中,MDSCs起着至关重要的作用.
新兴疗法旨在针对MDSC来增强抗瘤免疫力.
传统中国医学 (TCM) 在调节MDSC数量和功能方面显示出潜力.

结论:

MDSCs是瘤微环境和治疗点的关键调节者.
准MDSC可以潜在地克服瘤免疫逃避和治疗耐药性.
整合TCM通过调节MDSCs为传统癌症疗法提供了一种新的,补充性的方法.

关键词:

免疫抑制是一种免疫抑制.来自骨髓细胞的抑制细胞.传统的中国医学是传统的中国医学.瘤微环境是一个微环境.

更多相关视频

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...